序号 |
标题 |
次数 |
作者 |
发布时间 |
77671 |
cas:252554-78-2, Fmoc-Ala-Ser(Psi(Me Me)pro)-OH,(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 |
165 |
kx |
2024-12-19 |
77672 |
MC-Val-Cit-PAB-Indibulin, cas:2055896-95-0 |
113 |
WYQ |
2024-12-19 |
77673 |
cas:1884578-27-1 ,Alloc-Val-Ala-PAB-PNP,N-[(2-丙烯-1-基氧基)羰基]-L-缬氨酸-N-[4-[[(4-硝基苯氧基)羰基]氧基]甲基]苯基]-L-丙氨酸酰胺 |
129 |
kx |
2024-12-19 |
77674 |
mDPR-Val-Cit-PAB-MMAE(CAS:1491152-26-1) |
113 |
WYQ |
2024-12-19 |
77675 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
114 |
wyh |
2024-12-19 |
77676 |
MC-Val-Cit-PAB-vinblastine(CAS:2055896-92-7) |
117 |
WYQ |
2024-12-19 |
77677 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
106 |
wyh |
2024-12-19 |
77678 |
MC-Val-Cit-PAB-tubulysin5a(CAS:2055896-86-9) |
109 |
WYQ |
2024-12-19 |
77679 |
N-芴甲氧羰基-四聚乙二醇-VAL-ALA-PAB, Fmoc-PEG4-Val-Ala-PAB |
139 |
kx |
2024-12-19 |
77680 |
MC-Val-Cit-PAB-clindamycin(CAS号:1639793-13-7) |
95 |
WYQ |
2024-12-19 |
77681 |
MC-Val-Cit-PAB-carfilzomib,CAS号:2055896-83-6 |
129 |
WYQ |
2024-12-19 |
77682 |
叔丁酯-四聚乙二醇-VAL-ALA-PAB,Boc-PEG4-Val-Ala-PAB |
108 |
kx |
2024-12-19 |
77683 |
MC-Val-Cit-PAB-Auristatin E,CAS号:2055896-77-8 |
129 |
WYQ |
2024-12-19 |
77684 |
MC-Sq-Cit-PAB-Gefitinib(CAS:1941168-63-3) |
189 |
WYQ |
2024-12-19 |
77685 |
HS-(CH2)m-(EG)n -N(+)(CH3)2-CH2-COO(-) 聚乙二醇化直链烷烃硫醇 |
109 |
h |
2024-12-19 |
77686 |
Mal-PEG4-Val-Ala-PAB,马来酰亚胺-四聚乙二醇-VAL-ALA-PAB |
154 |
kx |
2024-12-19 |
77687 |
MC-GGFG-DX8951(CAS:1600418-29-8) |
331 |
WYQ |
2024-12-19 |
77688 |
(HO)2-PO-S-(CH2)6-EG2-OH 硫-(2-羟基六烷-1-基)硫代磷酸酯 |
154 |
h |
2024-12-19 |
77689 |
Au_55_C11EG4Carboxybetaine 金团簇55-羧基甜菜碱 |
151 |
h |
2024-12-19 |
77690 |
(HO)2-PO-S-(CH2)m-COONHS 硫-(2,5-二氧代 - 吡咯烷-1-基氧基羰基)-1-基硫代磷酸 |
125 |
h |
2024-12-19 |
77691 |
2529982-76-9,Azido-PEG4-Val-Ala-PAB,叠氮-四聚乙二醇-VAL-ALA-PAB |
140 |
kx |
2024-12-19 |
77692 |
Au_12_C11EG6 金团簇12-直链烷烃六聚乙二醇 |
177 |
h |
2024-12-19 |
77693 |
cas:863971-17-9 ,MC-Val-Cit-PAB-MMAF,MC-VAL-CIT-PAB-MMAF游离态 |
105 |
kx |
2024-12-19 |
77694 |
CF3-(CF2)5-C2-O-C11-Si(OMe)3 巯基-直链烷烃连接氟化硫醇和硅烷 |
137 |
h |
2024-12-19 |
77695 |
cas:2353409-69-3 , Mal-PEG8-Val-Cit-PAB-MMAE,马来酰亚胺-八聚乙二醇-VAL-CIT-PAB-MMAE |
122 |
kx |
2024-12-19 |
77696 |
cas:2129164-91-4 , DBCO-PEG4-Val-Cit-PAB-MMAE,二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-MMAE |
170 |
kx |
2024-12-19 |
77697 |
MAL-di-EG-Val-Cit-PAB-MMAF,由ADC连接桥(MAL-di-EG-Val-Cit-PAB)和有效的微管蛋白聚合阻断剂(MMAF, Monomethyl auristatin F)组成 |
139 |
WYQ |
2024-12-19 |
77698 |
MAL-di-EG-Val-Cit-PAB-MMAE,CAS编号:2746391-62-6 |
151 |
WYQ |
2024-12-19 |
77699 |
cas:644981-35-1 , Val-Cit-PAB-MMAE, ADC试剂 |
89 |
kx |
2024-12-19 |
77700 |
cas:2754384-60-4,DBCO-(PEG)3-VC-PAB-MMAE,抗体药物偶联物(ADC) |
171 |
kx |
2024-12-19 |
77701 |
AcLys-PABC-VC-Aur0101(CAS:1438851-17-2) |
126 |
WYQ |
2024-12-19 |
77702 |
反式环辛烯-MMAE,TCO-MMAE, ADC试剂 |
163 |
kx |
2024-12-19 |
77703 |
Hydrazone-doxorubicin,阿霉素-腙键偶联物 |
223 |
WYQ |
2024-12-19 |
77704 |
SPP-DM1(CAS号:452072-20-7)C44H59ClN4O14S2 |
180 |
WYQ |
2024-12-19 |
77705 |
氨基-二聚乙二醇-VG-N-双(一聚乙二醇-叠氮),Amino-PEG2-VG-N-Bis(PEG1-azide) |
103 |
kx |
2024-12-19 |
77706 |
DOTA-NHS ester,羟基琥珀酰亚胺-四氮杂环十二烷四乙酸(CAS号:170908-81-3) |
128 |
WYQ |
2024-12-19 |
77707 |
Maleimido-mono-amide-DOTA(CAS号:1006711-90-5) |
184 |
WYQ |
2024-12-19 |
77708 |
cas:2055041-40-0,Azido-PEG1-Val-Cit-PAB-OH,叠氮-一聚乙二醇-VAL-CIT-PAB-羟基 |
86 |
kx |
2024-12-19 |
77709 |
MB-VC-MGBA CAS号:932744-62-2 |
154 |
WYQ |
2024-12-19 |
77710 |
Anti-GPNMB-VC-MMAE-ADC抗体偶联药物 |
114 |
zyl |
2024-12-19 |
77711 |
MA-PEG8-VA-PAB-SG3199,硫醇反应SET™毒素 |
165 |
WYQ |
2024-12-19 |
77712 |
cas:1662687-83-3 , Mal-PEG2-Val-Cit-PABA,马来酰亚胺-二聚乙二醇-VAL-CIT-PABA |
99 |
kx |
2024-12-19 |
77713 |
Boc-Val-Ala-PAB cas:1884577-99-4 |
126 |
zyl |
2024-12-19 |
77714 |
perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate |
94 |
wyh |
2024-12-19 |
77715 |
MA-PEG4-VA-PBD(CAS号:2259318-50-6) |
131 |
WYQ |
2024-12-19 |